Characterization of the Proliferation State in Canine Mammary Tumors by the Standardized AgNOR Method with Postfixation and Immunohistologic Detection of Ki-67 and PCNA
Free accessResearch articleFirst published online May, 1997
Characterization of the Proliferation State in Canine Mammary Tumors by the Standardized AgNOR Method with Postfixation and Immunohistologic Detection of Ki-67 and PCNA
Paraffin-embedded tissue sections of 96 surgically removed mammary tumors from female dogs were analyzed for their proliferation state using three different methods. The AgNOR method, originally developed by Ploton and coworkers in 1986,34 modified and standardized by the AgNOR committee, is an easy, inexpensive silver-staining procedure used to determine cell proliferation and prognosis of various tumors. Due to the standardized staining protocol of the AgNOR method and a postfixation step, results obtained were of excellent quality for image analysis processing. The growth fraction was evaluated by counting of immuno-histologically positive-stained cells for Ki-67 or proliferating-cell nuclear antigen (PCNA). The values determined were, in general, lower with Ki-67 (MIB1) than with PCNA (PC10). Nevertheless, the labeling indices of these antigens correlated significantly (P < 0.001). Though the differences of the means between the tumor groups according to the classification system of the World Health Organization were significant for all three investigated methods (P < 0.001), there was a considerable overlap between the tumor groups concerning all investigated parameters. An exploratory data analysis (multivariate analysis) was performed to evaluate the prognostic relevance of the three methods including further anamnestic, clinical, gross, and histopathologic variables. Besides the histopathologic diagnosis (survival P < 0.001; survival time P < 0.05; reappearance of tumor growth P < 0.05), only the PCNA-labeling index (time until reappearance of tumor growth P < 0.001) was of prognostic significance.
AubeleMBiesterfeldSDerenziniMHufnagelPMartinHÖfnerDPlotonDRüschoffJ:
Guidelines of AgNOR quantitation.
Zentralbl Pathol140: 107–108,
1994
2.
BostockDEMoriartyJCrockerJ:
Correlation between histological diagnosis, mean nucleolar organizer regions count and prognosis in canine mammary tumors.
Vet Pathol29: 381–385,
1992
3.
BravoRCelisJE:
A search for differential polypeptide synthesis throughout the cell cycle of HeLa cells.
J Cell Biol84: 795–802,
1980
4.
BravoRFrankRBlundellPAMacDonald-BravoH:
Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ.
Nature326: 515–517,
1987
5.
BravoRMacDonald-BravoH:
Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle.
J Cell Biol105: 1549–1554,
1987
6.
CelisJEMadsenP:
Increased nuclear cyclin/PCNA antigen staining of non S-phase transformed human amnion cells engaged in nucleotide excision DNA repair.
FEBS Lett209: 277–283,
1986
7.
CrockerJ:
Molecular and immunohistological aspects of cell proliferation. In:
Molecular Biology in Histopathology, ed. CrockerJ, pp. 93–120.
J Wiley & Sons, New York,
1994
8.
DerenziniMPessionATrerèD:
The quantity of nucleolar silver-stained proteins is related to proliferating activity in cancer cells.
Lab Invest63: 137–140,
1990
9.
DestexheEVanmanshovenPCoignoulF:
Comparison of argyrophilic nucleolar organizer regions by counting and image analysis in canine mammary tumors.
Am J Vet Res56: 185–187,
1995
10.
DixonWJ, ed.:
BMDP Statistical Software Manual, vol.
1 and 2, pp. 44–47.
University of California Press, Berkeley,
1993
11.
DoverR:
Basic methods for assessing cellular proliferation. In:
Assessment of Cell Proliferation in Clinical Practice, ed. HallPA,
LevisonDA,
WrightNA, pp. 63–79.
Springer, London, UK,
1992
12.
Du ManoirSGuillaudPCamusESeigneurinDBrugalG:
Ki-67 labelling in postmitotic cells defines different Ki-67 pathways within the 2c compartment.
Cytometry12: 455–463,
1991
13.
FreseK:
Comparative pathology of mammary tumors in domestic animals. In:
Pathology of Neoplastic and Endocrine Induced Diseases of the Breast, ed. BässlerRHübnerK, pp. 44–61.
Gustav Fischer, Stuttgart, Germany,
1986
14.
GerdesJLemkeHBaischHWackerHHSchwabUSteinH:
Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.
J Immunol133: 1710–1715,
1984
15.
GerdesJLiLSchlueterCDuchrowMWohlenbergCGerlachCStahmerIKlothSBrandtEFladHD:
Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67.
Am J Pathol138: 867–873,
1991
16.
GerdesJSchwabULemkeHSteinH:
Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.
Int J Cancer31: 13–20,
1983
17.
HadjiolovAA:
The nucleolus and the ribosomal biogeneseis. In: The Cell Biology Monographs, ed. HadjiolovAA, pp. 1–267. Springer, Wien, Austria,
1985
18.
HallPACoatesPJGoodladRAHartIRLaneDP:
Proliferating cell nuclear antigen expression in non-cycling cells may be induced by growth factors `in vivo.'Br J Cancer70: 244–247,
1994
19.
HallPALevisonDA:
Assessment of cell proliferation in histological material.
J Clin Pathol43: 184–192,
1990
20.
HallPAWoodsAL:
Immunohistochemical markers of cellular proliferation: achievements, problems and prospects.
Cell Tissue Kinet23: 505–522,
1990
21.
HampeJFMisdorpW:
IX. Tumours and dysplasias of the mammary gland.
Bull World Health Organ50: 111–134,
1974
22.
HellménEBergströmRHombergLSpångbergIBHanssonKLindgrenA:
Prognostic factors in canine mammary tumors: a multivariate study of 202 consecutive cases.
Vet Pathol30: 20–27,
1993
23.
HofstädterFKnüchelRRüschoffJ:
Cell proliferation assessment in oncology.
Virchows Archiv427: 323–341,
1995
24.
Howard-PeeblesPNHowellWM:
Nucleolus organizer regions of the canine karyotype.
Cytogenet Cell Genet35: 293–294,
1983
25.
HsuSMRaineLFangerH:
Use of avidin-biotin-per-oxidase complex (ABC) in immunoperoxidase techniques.
J Histochem Cytochem29: 577–580,
1981
26.
HsuTCSpiritoSEPardueML:
Distribution of 18 + 28 ribosomal genes in mammalian genomes.
Chromosoma53: 25–36,
1975
27.
McCormickDYuCCWHobbsCHallPA:
The relevance of antibody concentration to the immunohistological quantification of cell proliferation associated antigens.
Histopathology22: 543–547,
1993
28.
MiyachiKFritzlerMJTanEM:
Autoantibody to a nuclear antigen in proliferating cells.
J Immunol121: 2228–2234,
1978
29.
MoultonJE:
Tumors of the mammary gland. In:
Tumors in Domestic Animals, ed. MoultonJE,
3rd ed., pp. 518–552.
University of California Press, Berkeley,
1990
30.
ÖfnerDAubeleMBiesterfeldSDerenziniMGiminez-MasJAHufnagelPPlotonDTrerèDRüschoffJ:
Guidelines of AgNOR quantification—first update. In: Hofstädter F, Knüchel R, and Rüschoff J: Cell proliferation assessment in oncology.
Virchows Archiv427: 340–341,
1995
31.
ÖfnerDRüschoffJTrerèDAubeleMDerenziniMSchmidKW:
Standardized morphometric silver stained nucleolus organiser region associated protein (AgNORs) analysis—basic concepts.
Path Res Pract191:236,
1995
32.
O'ReillySMRichardsMA:
Clinical aspects of assessing cell proliferation. In:
Assessment of Cell Proliferation in Clinical Practice, ed. HallPA,
LevisonDA,
WrightNA, pp. 63–79.
Springer, London, UK,
1992
33.
PardueMLHsuTC:
Locations of 18 S and 28 S ribo-somal genes on the chromosomes of the Indian mintjac.
J Cell Biol64: 251–254,
1975
34.
PlotonDMenagerMJeannessonPHimberGPigeonFAdnetJJ:
Improvement in the staining and in the visualization of argyrophilic proteins of the nucleolar organizer region at the optical level.
Histochem J18: 5–14,
1986
35.
PrehlichGTanCKKosturaMMathewsMBSoAGDowneyKMStilmanB:
Functional identity of proliferating cell nuclear antigen and DNA polymerase-δ auxiliary protein.
Nature326: 517–520,
1987
36.
RüschoffJPlateKHContractorHKernSZimmermannRThomasC:
Evaluation of nucleolus organizer regions (NORs) by automatic image analysis: a contribution to standardization.
J Pathol161: 113–118,
1990
37.
ToschiLBravoR:
Changes in cyclin/proliferating cell nuclear antigen distribution during DNA repair synthesis.
J Cell Biol107: 1623–1628,
1988
38.
YuCCWFilipeMI:
Review. Update on proliferation associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their clinical applications.
Histochem J25: 843–853,
1993
